Try our Advanced Search for more refined results

PTAB To Review Claims In Novartis' Dementia Patch Patents

By Allissa Wickham (October 15, 2014, 5:20 PM EDT) -- The U.S. Patent and Trademark Office's patent appeal board opted Tuesday to institute inter partes reviews of two Novartis AG patents covering its dementia treatment patch Exelon, finding petitioner Noven Pharmaceuticals Inc. had shown a reasonable likelihood of prevailing on its challenged claims....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Companies

Government Agencies

Patents

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!